Safety and Immunogenicity of Two Adjuvanted and One Non-adjuvanted H5N1 Influenza Vaccine in Adults

Mise à jour : Il y a 4 ans
Référence : NCT00382187

Femme et Homme

  • | Pays :
  • Italy
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The present study aims to evaluate safety and immunogenicity of two doses, administered three weeks apart, and a 6 month booster dose, of two influenza vaccines containing 7.5 micrograms or 15 micrograms of H5N1 influenza antigen, and of a non-adjuvanted influenza vaccine containing 15 micrograms of H5N1 influenza antigen, in adults


Critère d'inclusion

  • Influenza

Liens